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n July 2016, the closing of seven Seattle area pain clinics left 8,000 patients without care. Approximately three fourths of these patients were Medicaid patients (Aleccia, 2016a; Kim, 2016) . Although some patients were absorbed by local pain centers, others have faced multilevel barriers to accessing chronic noncancer pain (CNCP) management, such as long waitlists for a limited number of pain centers, insurance coverage restrictions, and limited CNCP management by primary care providers (Aleccia, 2016b) .
Lack of access to appropriate care is a growing public health concern as it poses a substantial burden on individuals and their communities. In the United States, more than 116 million adults experience chronic pain, which is more than the combined number of adults with cancer, heart disease, and diabetes (Institute of Medicine [IOM], 2011). Lack of access to pain management is a major source of work disability, lost productivity, and increased expenses related to health care for chronic pain. The resulting national economic cost is between $560 and $630 billion annually (IOM, 2011) . Those already vulnerable to having fewer resources are further challenged to buffer the negative effects of diminished access to care and may become even more vulnerable when pain management services become limited.
An inherent inequity exists among certain individuals in accessing care. Those with low socioeconomic status, older adults, racial/ethnic minorities, and women have disproportionately less access to high-quality, affordable pain management care (IOM, 2011; Mossey, 2011) . Recipients of Medicaid are considered a vulnerable group and tend to be at an elevated risk for poor health outcomes. This disparity in accessing care extends beyond mere differences or inequality and reflects inequities, which are unnecessary and avoidable as well as unfair and unjust differences (Whitehead, 1992) .
The root of these multilevel barriers stem from inequities that highlight some of the longstanding, pervasive issues faced by individuals who have CNCP in the United States. Events, such as the current opioid epidemic, can perpetuate negative societal attitudes about CNCP and those being treated for CNCP. These negative attitudes are problematic when there is little, if any, differentiation between the way individuals requiring CNCP management and others who engage in prescription opioid misuse and/or have dependence are addressed. However, reshaping societal attitudes toward CNCP and individuals with CNCP will not eliminate these inequitable barriers to care; the role of health care providers, and particularly, the responsibility of government and institutions should be considered. Government and institutions have been influential in the creation of the current opioid epidemic that has contributed to systemic inequities of access to CNCP management. Understanding the underlying political philosophy that drives these macro-level influencers provides a broader perspective from which to address current multilevel inequities to accessing CNCP management.
CNCP is a complex concept, as it is universal yet individually unique, measurable but largely subjective, and the etiologies of pain have been studied but much is unknown. For health care providers, this complexity can breed an intellectual understanding where there can be an inclination to direct blame and responsibility to patients for not accessing care. Self-awareness of this propensity is critically important to dismantling barriers to access to care that result from provider bias and stigma. Yet, this approach alone is not enough. A systemic issue exists that requires bringing to light the role and responsibility of government and institutions, pivotal to the transformation and sustainability of a culture of change from societal attitudes to provider biases. Specifically, the current state of inequity is a direct reflection of the tensions between the philosophies driving government and institutions versus the social good.
Neoliberalism is an underlying political philosophy that transforms citizens into consumers. Neoliberal rationality minimizes government intervention, as demonstrated by the shift of responsibility from government to the individual in the social determinants of health. From a neoliberal perspective, CNCP is a consequence of personal choice. Under this philosophy, the inability to access CNCP management and care for complications, such as addiction, is an inevitable inequality that is the fault of the individual rather than a failure of government. The neoliberal political paradigm honors the notion of personal choice over systemic inequity for issues of access to CNCP management.
Significant participation of government and institutions in the creation of the current opioid epidemic and the systemic barriers to accessing CNCP management has been overlooked. The rise in opioid drug use for the management of chronic pain has occurred parallel to an increase in prescription opioid drug abuse and addiction since the 1990s. These events are in part due to drug formulation alterations as well as changes with prescribing practices. Specifically, there was the pivotal introduction of OxyContin ® by Purdue Pharma and its promotion by national pain and health care organizations to address undertreated pain despite concerns and reluctance by medical providers to prescribe opioid agents. These events were a catalyst for a cascade of consequences that overshadowed any statements cautioning imprudent prescribing, risks, and life-threatening side effects with improper use (Kolodny et al., 2015; Rosenblum, Marsch, Joseph, & Portenoy, 2008) .
Governmentality and neoliberalism provide choice and responsibility to citizens. Under this framework, Purdue Pharma was playing its role as a free agent in a free market. Aggressive marketing was encouraged and largely embraced by government and institutions, implicitly and explicitly, and government policies had a lesser impact than the market force for OxyContin. Health, in this political climate, is a commodity.
The current sociopolitical climate provides an opportunity for nurses to respond. Beyond the individual level, there must be buy-in on the systemic level to sustain change. For instance, in current workplaces, assessing the organizational culture and attitude toward individuals with CNCP is the first step to opening discussions and identifying changes to systems in place that perpetuate stigma and bias. In addition, nurses Significant participation of government and institutions in the creation of the current opioid epidemic and the systemic barriers to accessing chronic noncancer pain management has been overlooked.
should be political advocates, regardless of partisanship. Historically, the foundation of the nursing profession and science has been holistic and inclusive for the good health of all individuals. Nurses serve as advocates for individuals and their health, which is not a commodity to market. Local and national nursing associations lead advocacy events and campaigns in which nurses with varying levels of political engagement and experience can participate. As the intragovernmental political divide deepens over health care access and coverage, the reduction or denial of the right to access even basic health care reflects the neoliberal tendency to prioritize capitalistic values over the social good. A culture of change is needed now, and nurses, as frontline health care providers and long-standing patient advocates, have a valuable and impactful voice that can lead this change.
